Parkinson's Disease Clinical Trial
Official title:
The Effects of Treadmill Versus Agility Training in Parkinson's Disease
Aim:
To determine the Responsiveness of the iMOBILITY in response to intensive physical therapy
exercise programs. (Is it sensitive to change?) Although exercise is thought to be the most
effective intervention for balance and gait in PD (compared to dopaminergic medication or
DBS surgery), the best exercise program for mobility in PD is unknown. The iMOBILITY will be
used to quantify balance and gait performance before and after two PT-supervised, intensive,
exercise programs, expected to improve balance and gait. The first program is a published
Treadmill training program and the second is the investigators new Agility training program
with sensorimotor progressions, targeted at specific impairments that underlie the
abnormalities of balance and gait in PD (developed for the Kinetics Foundation). This pilot
clinical trial will randomize 40 PD subjects into the two exercise programs at OHSU in
preparation for a larger clinical trial to determine the most effective exercise for
mobility disability in PD. The effects of exercise will be compared with no treatment during
a 5-week delay prior to start of exercise.
This trial will also determine the relative responsiveness (compared to traditional clinical
scales) of the iMOBILITY for testing the hypothesis that intensive exercise can improve
mobility in PD. We will use existing instruments (Berg Balance Scale, BEST of dynamic
balance, UPDRS, PDQ-39, 5 times sit-to-stand time and the Functional Performance Battery) to
show there is a difference between the exercise groups. Superior responsiveness of the
iMOBILITY system will be determined by larger differences with exercise intervention with
the iMOBILITY system than with traditional clinical measures of mobility in PD.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02915848 -
Long-term Stability of LFP Recorded From the STN and the Effects of DBS
|
||
Recruiting |
NCT03648905 -
Clinical Laboratory Evaluation of Chronic Autonomic Failure
|
||
Terminated |
NCT02688465 -
Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE).
|
Phase 4 | |
Completed |
NCT05040048 -
Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease
|
||
Active, not recruiting |
NCT04006210 -
Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations
|
Phase 3 | |
Completed |
NCT02562768 -
A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease
|
Phase 1 | |
Completed |
NCT00105521 -
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
|
Phase 3 | |
Completed |
NCT00105508 -
Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia
|
Phase 3 | |
Recruiting |
NCT06002581 -
Repetitive Transcranial Magnetic Stimulation(rTMS) Regulating Slow-wave to Delay the Progression of Parkinson's Disease
|
N/A | |
Completed |
NCT02236260 -
Evaluation of the Benefit Provided by Acupuncture During a Surgery of Deep Brain Stimulation
|
N/A | |
Completed |
NCT00529724 -
Body Weight Gain, Parkinson, Subthalamic Stimulation
|
Phase 2 | |
Active, not recruiting |
NCT05699460 -
Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
|
||
Completed |
NCT03703570 -
A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations
|
Phase 2 | |
Completed |
NCT03462680 -
GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures
|
N/A | |
Completed |
NCT02837172 -
Diagnosis of PD and PD Progression Using DWI
|
||
Not yet recruiting |
NCT04046276 -
Intensity of Aerobic Training and Neuroprotection in Parkinson's Disease
|
N/A | |
Recruiting |
NCT02952391 -
Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol
|
N/A | |
Active, not recruiting |
NCT02937324 -
The CloudUPDRS Smartphone Software in Parkinson's Study.
|
N/A | |
Completed |
NCT02927691 -
Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial
|
Phase 2 | |
Completed |
NCT02874274 -
Vaccination Uptake (VAX) in PD
|
N/A |